| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |